CCCCC4 Therapeutics, Inc.
4.000USD-4.99%Mkt Cap: 492.10M $P/E: —3d ago
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally bioavailable monodac targ…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap492.10M $
Enterprise Value298.99M $
Revenue (TTM)35.04M $
Gross Profit30.25M $
Net Income (TTM)-104.99M $
Revenue/Share0.3140 USD
Last Price4.000 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees104
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.04
PEG—
EV/EBITDA-3.01
EV/Revenue8.53
P/S14.15
P/B2.00
EPS (TTM)-0.87
EPS (Forward)-1.00
52W Range
1.69066% of range5.170
52W High5.170 USD
52W Low1.690 USD
Profitability
Gross Margin86.34%
Oper. Margin-397.88%
EBITDA Margin-283.82%
Profit Margin-292.08%
ROE-40.92%
ROA-29.24%
Growth
Revenue Growth2.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-98.69M $
CapEx (TTM)607.00K $
FCF Margin-124.62%
FCF Yield-8.87%
Net Debt-196.81M $
Net Debt/EBITDA1.98
Balance Sheet
Debt/Equity0.23
Current Ratio5.45
Quick Ratio5.29
Book Value/Sh2.012 USD
Cash/Share2.062 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)13.33 USD
Upside (mean)+233.3%
Target Range7.000 USD – 30.00 USD
$7.000+233.3% to mean$30.00
# Analysts6
Ownership
Shares Out.123.03M
Float94.52M
Insiders0.83%
Institutions102.03%
Short Interest
Short Ratio9.2d
Short % Float24.88%
Short % Out.24.73%
Shares Short30.43M
Short (prev mo.)25.00M
Technical
SMA 503.932 (+1.7%)
SMA 2002.960 (+35.1%)
Beta2.95
S&P 52W Chg18.16%
Avg Vol (30d)2.56M
Avg Vol (10d)2.57M
Technical Indicators
RSI (14)54.3
MACD0.0865
MACD Signal0.0204
MACD Hist.+0.0661
BB Upper4.297 USD
BB Middle3.757 USD
BB Lower3.217 USD
BB Width28.74%
ATR (14)0.2568 USD
Vol Ratio (20d)0.48x